Your browser doesn't support javascript.
loading
Optimizing immunization protocols to elicit broadly neutralizing antibodies.
Sprenger, Kayla G; Louveau, Joy E; Murugan, Pranav M; Chakraborty, Arup K.
Afiliación
  • Sprenger KG; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Louveau JE; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Murugan PM; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139.
  • Chakraborty AK; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139; arupc@mit.edu.
Proc Natl Acad Sci U S A ; 117(33): 20077-20087, 2020 08 18.
Article en En | MEDLINE | ID: mdl-32747563
ABSTRACT
Natural infections and vaccination with a pathogen typically stimulate the production of potent antibodies specific for the pathogen through a Darwinian evolutionary process known as affinity maturation. Such antibodies provide protection against reinfection by the same strain of a pathogen. A highly mutable virus, like HIV or influenza, evades recognition by these strain-specific antibodies via the emergence of new mutant strains. A vaccine that elicits antibodies that can bind to many diverse strains of the virus-known as broadly neutralizing antibodies (bnAbs)-could protect against highly mutable pathogens. Despite much work, the mechanisms by which bnAbs emerge remain uncertain. Using a computational model of affinity maturation, we studied a wide variety of vaccination strategies. Our results suggest that an effective strategy to maximize bnAb evolution is through a sequential immunization protocol, wherein each new immunization optimally increases the pressure on the immune system to target conserved antigenic sites, thus conferring breadth. We describe the mechanisms underlying why sequentially driving the immune system increasingly further from steady state, in an optimal fashion, is effective. The optimal protocol allows many evolving B cells to become bnAbs via diverse evolutionary paths.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / Esquemas de Inmunización / Vacunación / Anticuerpos Neutralizantes Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Virales / Esquemas de Inmunización / Vacunación / Anticuerpos Neutralizantes Límite: Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2020 Tipo del documento: Article